Home › Funds › Sofinnova Investments, Inc. › MANE
Sofinnova Investments, Inc. position in MANE
VERADERMICS INC · Health Care
Sofinnova Investments, Inc. reported holding 148,993 shares of MANE (VERADERMICS INC) in its Q2 2026 13F filing — a position valued at US$18.3M, representing 0.98% of its reported portfolio and ranking #26 among its reported holdings. Sofinnova Investments, Inc. has disclosed MANE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Sofinnova Investments, Inc.'s MANE position evolved
Sofinnova Investments, Inc. first disclosed a stake in MANE in Q1 2026 at 73,315 shares (US$4.6M). The position peaked in Q2 2026 at 148,993 shares, worth US$18.3M. Across 2 filings, Sofinnova Investments, Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 148,993 shares valued at US$18.3M — an increase of 75,678 shares quarter over quarter.. Notable position changes include a 103% increase in Q2 2026 (shares fell 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 73.31K | $4.63M | New |
| Q2 2026 | 148.99K | $18.32M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MANE and 13F data
MANE (VERADERMICS INC) is a Health Care company. 180 other funds we track also report a position in MANE — the largest reported positions include MONTANOVA CAPITAL, LLC (US$512.5M), SR ONE CAPITAL MANAGEMENT, LP (US$295.3M), Deep Track Capital, LP (US$245.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MANE
- MONTANOVA CAPITAL, LLC 4.17M sh · $512.53M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 2.40M sh · $295.29M · Q2 2026
- Deep Track Capital, LP 2.00M sh · $245.88M · Q2 2026
- Siren, L.L.C. 1.66M sh · $203.51M · Q2 2026
- Maverick Capital 789.98K sh · $97.12M · Q2 2026
- MAVERICK CAPITAL LTD 789.98K sh · $97.12M · Q2 2026
- INFINITUM ASSET MANAGEMENT, LLC 731.15K sh · $89.89M · Q2 2026
- EMERALD ADVISERS, LLC 288.37K sh · $35.45M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 209.92K sh · $25.81M · Q2 2026
- Logos Global Management LP 180.00K sh · $22.13M · Q2 2026
- Kalehua Capital Management LLC 145.69K sh · $17.91M · Q2 2026
- SEVEN GRAND MANAGERS, LLC 125.00K sh · $15.37M · Q2 2026
More on Sofinnova Investments, Inc.
FAQ
How long has Sofinnova Investments, Inc. held MANE?
Sofinnova Investments, Inc. has disclosed MANE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Sofinnova Investments, Inc.'s current position in MANE?
As of Q2 2026, Sofinnova Investments, Inc. holds 148.99K shares of MANE (VERADERMICS INC), valued at $18.32M, representing 0.98% of its reported portfolio and ranking #26.
Has Sofinnova Investments, Inc. been buying or selling MANE?
In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. increased its position in MANE. The position peaked in Q2 2026 at 148.99K shares.
Which other funds hold MANE?
Other major institutional holders of MANE include MONTANOVA CAPITAL, LLC, SR ONE CAPITAL MANAGEMENT, LP, Deep Track Capital, LP, among 180 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.